Serum Metabolites and Kidney Outcomes: The Atherosclerosis Risk in Communities StudyPlain Language Summary

Serum Metabolites and Kidney Outcomes: The Atherosclerosis Risk in Communities StudyPlain Language Summary

Rationale & Objective: Novel metabolite biomarkers of kidney failure with replacement therapy (KFRT) may help identify people at high risk for adverse kidney outcomes and implicated pathways may aid in developing targeted therapeutics. Study Design: Prospective cohort. Setting & Part...

Full description

Bibliographic Details
Main Authors:	Lauren Bernard, Linda Zhou, Aditya Surapaneni, Jingsha Chen, Casey M. Rebholz, Josef Coresh, Bing Yu, Eric Boerwinkle, Pascal Schlosser, Morgan E. Grams
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	Kidney Medicine
Subjects:	1-Linoleoylglycerophosphocholine 1,5-anhydroglucitrol 5-oxoproline CKD progression end-stage kidney disease gamma-glutamylthreonine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059522001443

Similar Items

Cyst fluid metabolites distinguish malignant from benign pancreatic cysts
by: Jiaqi Shi, et al.
Published: (2021-11-01)

APOL1, Sickle Cell Trait, and CKD in the Jackson Heart StudyPlain-Language Summary
by: Bessie A. Young, et al.
Published: (2021-11-01)

Synthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptides
by: Victor P. Krasnov, et al.
Published: (2023-11-01)

Acetaminophen Use Concomitant with Long-Lasting Flucloxacillin Therapy: A Dangerous Combination
by: Luuk René van den Bersselaar, et al.
Published: (2020-04-01)

Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer
by: Weijia Wang, et al.
Published: (2023-12-01)

Demethionylation of Pro-1 variants of 4-oxalocrotonate tautomerase in Escherichia coli by co-expression with an engineered methionine aminopeptidase
by: Bert-Jan Baas, et al.
Published: (2014-01-01)

Estimated GFR, Albuminuria, and Physical Function: The Brain in Kidney Disease (BRINK) Cohort StudyPlain-Language Summary
by: Ryan Mello, et al.
Published: (2022-10-01)

The Emerging Roles of γ-Glutamyl Peptides Produced by γ-Glutamyltransferase and the Glutathione Synthesis System
by: Yoshitaka Ikeda, et al.
Published: (2023-12-01)

Causal relationships between genetically determined metabolites and human intelligence: a Mendelian randomization study
by: Jian Yang, et al.
Published: (2021-02-01)

Performance of Glomerular Filtration Rate Estimating Equations Before and After Bariatric SurgeryPlain-Language Summary
by: Alex R. Chang, et al.
Published: (2020-11-01)

Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) StudyPlain-Language Summary
by: Jonathan J. Taliercio, et al.
Published: (2022-11-01)

Cardiac Valve Disease and Prevalent and Incident CKD in Community-Dwelling Older Adults: The Atherosclerosis Risk in Communities (ARIC) StudyPlain-Language Summary
by: Vedika M. Karandikar, et al.
Published: (2022-12-01)

Retinopathy and Risk of Kidney Disease in Persons With DiabetesPlain-Language Summary
by: Jingyao Hong, et al.
Published: (2021-09-01)

APOL1 Genotype, Proteinuria, and the Risk of Kidney Failure: A Secondary Analysis of the AASK (African American Study of Kidney Disease and Hypertension) and CRIC (Chronic Renal Insufficiency Cohort) StudiesPlain-Language Summary
by: Anthony Nguyen, et al.
Published: (2022-12-01)

How Glutamate Is Managed by the Blood–Brain Barrier
by: Richard A. Hawkins, et al.
Published: (2016-10-01)

Integrated proteomic and metabolomic modules identified as biomarkers of mortality in the Atherosclerosis Risk in Communities study and the African American Study of Kidney Disease and Hypertension
by: Linda Zhou, et al.
Published: (2022-11-01)

Outcome of hemodialysis in elderly diabetic patients: a single-center experience
by: Hatem Darwish, et al.
Published: (2015-01-01)

Obesity and the Risk of Low Bicarbonate: A Cohort StudyPlain-Language Summary
by: Douglas C. Lambert, et al.
Published: (2021-07-01)

Impact of Kidney Failure Risk Prediction Clinical Decision Support on Monitoring and Referral in Primary Care Management of CKD: A Randomized Pragmatic Clinical TrialPlain-Language Summary
by: Lipika Samal, et al.
Published: (2022-07-01)

Burnout Among Nephrologists in the United States: A Survey StudyPlain-Language Summary
by: Devika Nair, et al.
Published: (2022-03-01)

Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis
by: Pajaree Krisanapan, et al.
Published: (2024-01-01)

Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016Plain-language summary
by: Julie Z. Zhao, et al.
Published: (2021-03-01)

Kidney Failure Patients’ Perceptions and Definitions of Health: A Qualitative StudyPlain-Language Summary
by: Renata Sledge, et al.
Published: (2023-04-01)

Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort StudyPlain Language Summary
by: Nancy L. Reaven, et al.
Published: (2023-05-01)

Hemodialysis Access Type and Access Patency Loss: An Observational Cohort StudyPlain-Language Summary
by: Nicholas S. Roetker, et al.
Published: (2023-01-01)

Serum Potassium and Mortality Risk in Hemodialysis Patients: A Cohort StudyPlain-Language Summary
by: Esther N.M. de Rooij, et al.
Published: (2022-01-01)

Urgent Start Peritoneal Dialysis: A Population-Based Cohort StudyPlain-Language Summary
by: Neelam M. Bhalla, et al.
Published: (2022-03-01)

Dietary Patterns, Apolipoprotein L1 Risk Genotypes, and CKD Outcomes Among Black Adults in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort StudyPlain-Language Summary
by: Titilayo O. Ilori, et al.
Published: (2023-05-01)

High-Phosphate-Stimulated Macrophage-Derived Exosomes Promote Vascular Calcification via let-7b-5p/TGFBR1 Axis in Chronic Kidney Disease
by: Qing Li, et al.
Published: (2022-12-01)

Ertapenem-induced neurotoxicity in an end-stage renal disease patient on intermittent haemodialysis: a case report
by: Shamira Shahar, et al.
Published: (2022-11-01)

Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4–5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial
by: Fabio Solis-Jimenez, et al.
Published: (2022-09-01)

Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative StudyPlain-Language Summary
by: Dorothee Oberdhan, et al.
Published: (2023-02-01)

Experiences With Kidney Transplant Among Undocumented Immigrants in Illinois: A Qualitative StudyPlain-Language Summary
by: Yumiko I. Gely, et al.
Published: (2023-06-01)

Frailty and Clinical Outcomes in Patients Treated With Hemodialysis: A Prospective Cohort StudyPlain language summary
by: Marcello Tonelli, et al.
Published: (2023-08-01)

Mycophenolate Mofetil for Severe IgA Vasculitis Nephropathy in Children: An Observational StudyPlain-Language Summary
by: Dmitry Samsonov, et al.
Published: (2022-10-01)

Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC StudyPlain-Language Summary
by: Rebecca Frazier, et al.
Published: (2022-01-01)

Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort
by: Eleni Stamellou, et al.
Published: (2024-02-01)

Estimated GFR With Cystatin C and Creatinine in Clinical Practice: A Retrospective Cohort StudyPlain-Language Summary
by: Eric Raphael Gottlieb, et al.
Published: (2023-03-01)

Patient-Centered Outcomes With a Multidisciplinary CKD Care Team Approach: An Observational StudyPlain-Language Summary
by: Surekha Annadanam, et al.
Published: (2023-04-01)

CKD Progression Risk and Subsequent Cause of Death: A Population-Based Cohort StudyPlain-Language Summary
by: Nayanjot K. Rai, et al.
Published: (2023-04-01)